Select Medical (NYSE:SEM) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of Select Medical (NYSE:SEM - Free Report) from a hold rating to a buy rating in a report published on Friday.

A number of other equities research analysts have also weighed in on SEM. Royal Bank of Canada upped their target price on shares of Select Medical from $40.00 to $47.00 and gave the stock an "outperform" rating in a report on Monday, November 4th. Benchmark lowered Select Medical from a "buy" rating to a "hold" rating in a report on Monday, November 25th. Finally, UBS Group cut their target price on Select Medical from $40.00 to $21.00 and set a "neutral" rating on the stock in a research report on Friday, January 3rd. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $27.25.

Select Medical Stock Up 4.7 %

NYSE:SEM traded up $0.83 on Friday, hitting $18.51. The stock had a trading volume of 1,225,852 shares, compared to its average volume of 871,570. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. Select Medical has a 52 week low of $16.20 and a 52 week high of $40.98. The business's fifty day moving average is $19.07 and its 200 day moving average is $27.81. The company has a market cap of $2.40 billion, a PE ratio of 11.22, a P/E/G ratio of 0.64 and a beta of 1.45.

Select Medical (NYSE:SEM - Get Free Report) last announced its quarterly earnings results on Thursday, February 20th. The health services provider reported $0.18 EPS for the quarter, missing analysts' consensus estimates of $0.29 by ($0.11). Select Medical had a net margin of 3.23% and a return on equity of 14.04%. The business had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.50 billion. On average, equities research analysts expect that Select Medical will post 1.17 EPS for the current fiscal year.

Select Medical Cuts Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 13th. Stockholders of record on Monday, March 3rd will be paid a $0.0625 dividend. The ex-dividend date is Monday, March 3rd. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.35%. Select Medical's payout ratio is presently 30.30%.

Insider Activity

In related news, VP Robert G. Breighner, Jr. sold 4,989 shares of the business's stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the transaction, the vice president now directly owns 30,356 shares of the company's stock, valued at approximately $605,602.20. The trade was a 14.12 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Marilyn B. Tavenner sold 32,000 shares of the firm's stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the sale, the director now owns 22,000 shares of the company's stock, valued at $463,980. This trade represents a 59.26 % decrease in their position. The disclosure for this sale can be found here. 19.14% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Quarry LP purchased a new stake in shares of Select Medical during the 3rd quarter worth approximately $30,000. Smartleaf Asset Management LLC increased its position in Select Medical by 179.0% in the fourth quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider's stock worth $43,000 after buying an additional 1,473 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new stake in shares of Select Medical in the third quarter valued at $81,000. Covestor Ltd lifted its position in shares of Select Medical by 33.5% during the 4th quarter. Covestor Ltd now owns 4,955 shares of the health services provider's stock valued at $93,000 after buying an additional 1,244 shares during the last quarter. Finally, Mount Yale Investment Advisors LLC bought a new position in shares of Select Medical during the 3rd quarter worth $193,000. 89.48% of the stock is currently owned by hedge funds and other institutional investors.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.